Method for predicting the occurrence of metastasis in breast cancer patients

Details for Australian Patent Application No. 2008220841 (hide)

Owner INSERM (Institut National de la Sante et de la Recherche Medicale) Centre Rene Huguenin

Inventors Landemaine, Thomas; Lidereau, Rosette; Driouch, Keltouma

Agent Watermark

Pub. Number AU-A-2008220841

PCT Pub. Number WO2008/104543

Priority 07300823.7 26.02.07 EP

Filing date 26 February 2008

Wipo publication date 4 September 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/104543 Priority application(s): WO2008/104543

28 April 2011 Assignment before Grant

  Centre Rene Huguenin; INSERM (Institut National de la Sante et de la Recherche Medicale) The application has been assigned to INSERM (Institut National de la Sante et de la Recherche Medicale); L'Institut Curie

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008220845-Medicated chewing gum

2008220838-Video call device control